CLINICAL_TRIALS
trial_result
· 2023-08-24
Clinical Trial Update: Arimoclomol in Amyotropic Lateral Sclerosis [Phase 3]
Summary
Phase 3 trial of arimoclomol in amyotrophic lateral sclerosis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ZevraDenmark | Conditions: Amyotrophic Lateral Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2023-08-24